Markus Ruhnke

19.3k total citations · 2 hit papers
151 papers, 7.0k citations indexed

About

Markus Ruhnke is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Markus Ruhnke has authored 151 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Infectious Diseases, 102 papers in Epidemiology and 34 papers in Oncology. Recurrent topics in Markus Ruhnke's work include Antifungal resistance and susceptibility (94 papers), Fungal Infections and Studies (74 papers) and Pneumocystis jirovecii pneumonia detection and treatment (30 papers). Markus Ruhnke is often cited by papers focused on Antifungal resistance and susceptibility (94 papers), Fungal Infections and Studies (74 papers) and Pneumocystis jirovecii pneumonia detection and treatment (30 papers). Markus Ruhnke collaborates with scholars based in Germany, United States and United Kingdom. Markus Ruhnke's co-authors include Matthias Trautmann, Georg Maschmeyer, Oliver A. Cornely, Grzegorz Kofla, Joachim Morschhäuser, Raoul Herbrecht, R. Franz, Patricia Ribaud, Dieter Buchheidt and David W. Denning and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Markus Ruhnke

149 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis

2002 643 citations Markus Ruhnke et al. profile →
Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High-Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)

2007 486 citations Oliver A. Cornely, Andrew J. Ullmann et al. profile →

Peers

Countries citing papers authored by Markus Ruhnke

Since Specialization

Citations

This map shows the geographic impact of Markus Ruhnke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Ruhnke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Ruhnke more than expected).

Fields of papers citing papers by Markus Ruhnke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Ruhnke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Ruhnke. The network helps show where Markus Ruhnke may publish in the future.

Co-authorship network of co-authors of Markus Ruhnke

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Ruhnke. A scholar is included among the top collaborators of Markus Ruhnke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Ruhnke. Markus Ruhnke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO) 2017 ·Annals of Hematology ·Werner Heinz, Dieter Buchheidt, Maximilian Christopeit, Marie von Lilienfeld‐Toal, Oliver A. Cornely, Hermann Einsele, Meinolf Karthaus, Hartmut Link, Rolf Mahlberg, Silke Neumann, Helmut Ostermann, Olaf Penack, Markus Ruhnke, Michael Sandherr, Xaver Schiel, Jörg Janne Vehreschild, Florian Weißinger, Georg Maschmeyer	100
2	Invasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006–2008) 2014 ·Clinical Microbiology and Infection ·Lena Klingspor, Anna Maria Tortorano, Javier Pemán, Birgit Willinger, Petr Hamal, Boualem Sendid, Aristea Velegraki, Christopher C. Kibbler, Jacques F. Meis, Raquel Sabino, Markus Ruhnke, Sevtap Arıkan-Akdağlı, Juha Salonen, Ilona Dóczi	97
3	Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study 2012 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown), Georg Maschmeyer, Werner Heinz, Bernd Hertenstein, Heinz A. Horst, (unknown), Thomas Wagner, Oliver A. Cornely, Jürgen Löffler, Markus Ruhnke	15
4	Efficacy and safety of anidulafungin in elderly, critically ill patients with invasive Candida infections: a post hoc analysis 2012 ·International Journal of Antimicrobial Agents ·George Dimοpoulos, José Artur Paiva, Wouter Meersseman, Jan Pachl, Ioana Grigoraș, Gabriele Sganga, Philippe Montravers, Georg Auzinger, (unknown), Paul Miller, (unknown), Michal Kantecki, Markus Ruhnke	14
5	Current issues in the clinical management of invasive candida infections – the AGIHO, DMykG, ÖGMM and PEG web‐based survey and expert consensus conference 2009 2011 ·Mycoses ·Meinolf Karthaus, Maria J. G. T. Rüping, Oliver A. Cornely, Angela Steinbach, Andreas H. Groll, Cornelia Lass‐Flörl, Helmut Ostermann, Markus Ruhnke, Jörg Janne Vehreschild	12
6	Current issues in the clinical management of invasive aspergillosis – the AGIHO, DMykG, ÖGMM and PEG web‐based survey and expert consensus conference 2009 2011 ·Mycoses ·Maria J. G. T. Rüping, Jörg Janne Vehreschild, Andreas H. Groll, Cornelia Lass‐Flörl, Helmut Ostermann, Markus Ruhnke, Oliver A. Cornely	20
7	Diagnosis of chronic disseminated candidosis from liver biopsies by a novel PCR in patients with haematological malignancies 2011 ·Clinical Microbiology and Infection ·Michael Fleischhacker, Stefan Schulz, Korinna Jöhrens, Marie von Lilienfeld‐Toal, Thomas Held, Ellen Fietze, (unknown), Iver Petersen, Markus Ruhnke	13
8	Longitudinal Genotyping of Candida dubliniensis Isolates Reveals Strain Maintenance, Microevolution, and the Emergence of Itraconazole Resistance 2010 ·Journal of Clinical Microbiology ·Michael Fleischhacker, (unknown), Gary P. Moran, Markus Ruhnke	16
9	Comparison of Phenotypic Methods for the Identification of Candida dubliniensis 2010 ·Journal of Microbiology Immunology and Infection ·(unknown), (unknown), Michael Fleischhacker, Markus Ruhnke	17
10	Effect of different sample volumes on the DNA extraction of Aspergillus fumigatus from whole blood 2009 ·Clinical Microbiology and Infection ·(unknown), (unknown), (unknown), (unknown), Markus Ruhnke	7
11	Secretion of E , E -Farnesol and Biofilm Formation in Eight Different Candida Species 2008 ·Antimicrobial Agents and Chemotherapy ·(unknown), Reinhard Sohr, (unknown), Michael Fleischhacker, Markus Ruhnke	75
12	Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology 2008 ·Haematologica ·Oliver A. Cornely, Angelika Böhme, Dieter Buchheidt, H. Einsele, Werner Heinz, Meinolf Karthaus, Stefan W. Krause, William Krüger, Georg Maschmeyer, Olaf Penack, J. Ritter, Markus Ruhnke, Michael Sandherr, Michal Sieniawski, Jörg Janne Vehreschild, Hans‐Heinrich Wolf, Andrew J. Ullmann	137
13	Candidose der Haut 2006 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·C Seebacher, Dietrich Abeck, Jochen Brasch, Isaak Effendy, Gabriele Ginter‐Hanselmayer, (unknown), (unknown), Herbert Hof, Hans Christian Körting, Peter Mayser, Markus Ruhnke, (unknown), Hans‐Jürgen Tietz	7
14	Tap Water Colonization With Psmdomonas aeruginosa in a Surgical Intensive Care Unit (ICU) and Relation to Psmdomonas Infections of ICU Patients 2001 ·Infection Control and Hospital Epidemiology ·Matthias Trautmann, (unknown), H Wiedeck, Vladan Radosavljević, Markus Ruhnke	100
15	Therapie von Pilzinfektionen in der Hämatologie und Onkologie 2001 ·DMW - Deutsche Medizinische Wochenschrift ·(unknown), Markus Ruhnke, (unknown), (unknown), (unknown), Gudula Heußel, Claus Peter Heußel, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
16	Infektionsprophylaxe bei neutropenischen Patienten 2000 ·DMW - Deutsche Medizinische Wochenschrift ·(unknown), J. Beyer, Angelika Böhme, Dieter Buchheidt, Oliver A. Cornely, H. Einsele, Jens Kisro, (unknown), Georg Maschmeyer, Markus Ruhnke, Christian A. Schmidt, Stefan Schwartz, Hubert Szelényi	10
17	Regression of Epstein-Barr virus-associated lymphoproliferative disorders in patients with acquired immunodeficiency syndrome during therapy with foscarnet 2000 ·Annals of Hematology ·Udo Schneider, Markus Ruhnke, Henri‐Jacques Delecluse, H. Stein, D. Huhn	14
18	TREATMENT OF EPSTEIN-BARR VIRUS-INDUCED POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER WITH FOSCARNET ALONE IN AN ADULT AFTER SIMULTANEOUS HEART AND RENAL TRANSPLANTATION 1999 ·Transplantation ·Stephan Oertel, Markus Ruhnke, Ioannis Anagnostopoulos, Andreas Kahl, (unknown), Wolf O. Bechstein, Manfred Hummel, Hanno Riess	24
19	Standardisierte pathologische Untersuchung von Mamma-Exzisionspräparaten Relevanz innerhalb eines interdisziplinären Praxisprotokolls für das Qualitätsmanagement der brusterhaltenden Therapie 1997 ·Der Pathologe ·Thomas Decker, Markus Ruhnke, W Schneider	1
20	Duktale Hyperplasie und Duktales Carcinoma in situ Definition – Klassifikation – Differentialdiagnose 1997 ·Der Pathologe ·W. Böcker, Thomas Decker, Markus Ruhnke, W. Schneider	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact